紫鑫藥業(002118.SZ)業績快報:2020年度業績盈轉虧至6.54億元
格隆匯 2 月 25日丨紫鑫藥業(002118.SZ)披露2020年度業績快報,實現營業總收入2.86億元,同比下降66.75%;營業利潤-6.88億元;利潤總額-6.99億元;歸屬於上市公司股東的淨虧損6.54億元,上年同期盈利7028.99萬元;基本每股虧損0.51元。
2020年公司業務結構未發生重大變化。受國內外新型冠狀病毒疫情影響,公司復工復產延遲,導致主營業務收入和利潤同比雙降,全年度經營業績出現虧損,第二季度以來,隨着國內疫情形勢逐步得到控制,以及國家一系列支持復工復產穩定經濟政策措施的出台,公司生產經營得以恢復;2020年第四季度虧損幅度減少,但整體經營業績有所放緩,人蔘板塊銷售終端因上半年疫情期間停滯,需重新夯實搭建,同時人蔘深加工產品提取物出口港澳業務受到宏觀經濟及政策形勢影響基本停滯,總體對公司人蔘板塊業務帶來極大影響。另外,公司柳河醫藥產業園等項目陸續達到使用狀態,相關折舊費用增加。
同時,根據《企業會計準則第8號-資產減值》、《深圳證券交易所上市公司規範運作指引》(2020年修訂)及公司相關會計政策的規定,為更加真實公允地反映公司截止2020年12月31日的財務狀況及2020年度經營成果,公司及下屬子公司對2020年末各類資產進行了全面清查及資產減值測試後,對存在減值跡象的存貨、無形資產、固定資產等計提相應的減值準備。2020年度計提資產減值準備2.96億元。計入公司2020年度損益,減少公司2020年度淨利潤2.6億元。
綜上原因,致使公司2020年的整體業績與去年同期相比大幅下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.